화학공학소재연구정보센터
검색결과 : 228건
No. Article
81 The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1(-/-) murine model of ovarian cancer
Huang J, Wang L, Cong ZY, Amoozgar Z, Kiner E, Xing DY, Orsulic S, Matulonis U, Goldberg MS
Biochemical and Biophysical Research Communications, 463(4), 551, 2015
82 Leukocyte-associated immunoglobulin-like receptor-1 expressed in epithelial ovarian cancer cells and involved in cell proliferation and invasion
Cao QZ, Fu AL, Yang SD, He XL, Wang Y, Zhang XS, Zhou JD, Luan XY, Yu WZ, Xue JN
Biochemical and Biophysical Research Communications, 458(2), 399, 2015
83 beta-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cells
Fu QY, Chen Z, Gong XH, Cai YF, Chen Y, Ma X, Zhu RY, Jin J
Biochemical and Biophysical Research Communications, 461(1), 21, 2015
84 Transforming growth factor-alpha induces human ovarian cancer cell invasion by down-regulating E-cadherin in a Snail-independent manner
Qiu X, Cheng JC, Klausen C, Fan QL, Chang HM, So WK, Leung PCK
Biochemical and Biophysical Research Communications, 461(1), 128, 2015
85 OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer
Liu L, Zhang J, Fang C, Zhang ZB, Feng YJ, Xi XW
Biochemical and Biophysical Research Communications, 461(3), 525, 2015
86 EpCAM is up-regulated by EGF via ERK1/2 signaling and suppresses human epithelial ovarian cancer cell migration
Fan QL, Cheng JC, Qiu X, Chang HM, Leung PCK
Biochemical and Biophysical Research Communications, 457(3), 256, 2015
87 Segregation of Ovarian Cancer Stage Exploiting Spectral Biomarkers Derived from Blood Plasma or Serum Analysis: ATR-FTIR Spectroscopy Coupled with Variable Selection Methods
Lima KMG, Gajjar KB, Martin-Hirsch PL, Martin FL
Biotechnology Progress, 31(3), 832, 2015
88 Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
Zi D, Zhou ZW, Yang YJ, Huang L, Zhou ZL, He SM, He ZX, Zhou SF
International Journal of Molecular Sciences, 16(11), 27228, 2015
89 High Levels of KAP1 Expression Are Associated with Aggressive Clinical Features in Ovarian Cancer
Cui YF, Yang SB, Fu X, Feng JW, Xu SL, Ying GG
International Journal of Molecular Sciences, 16(1), 363, 2015
90 Biocompatible APTES-PEG Modified Magnetite Nanoparticles: Effective Carriers of Antineoplastic Agents to Ovarian Cancer
Javid A, Ahmadian S, Saboury AA, Kalantar SM, Rezaei-Zarchi S, Shahzad S
Applied Biochemistry and Biotechnology, 173(1), 36, 2014